Judge Dismisses Fraud, Misrepresentation Claims Against Plavix Makers



DOCUMENTS
  • Order


TRENTON, N.J. - A New Jersey federal judge has dismissed state law fraud and negligent misrepresentation claims brought against Bristol Meyers Squibb-Co. and Sanofi-Aventis U.S. Inc. in connection with their marketing and sale of the anti-blood clotting drug Plavix. Money v. Bristol-Meyers Squibb Co., et al., No. 3:07-110 (D. N.J.)

In a Dec. 30 order, Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey ruled that the claims, brought under Oklahoma state law, were inadequately pled.

In 2007, Dale Money, an Oklahoma resident, sued Bristol Myers-Squibb Co., Sanofi-Aventis U.S. L.L.C., Sanofi-Aventis U.S. Inc. and …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS